Who is TRISOMY test designed for? - TRISOMYtest.sk - neinvazívne skríningové vyšetrenie z krvi matky

TRISOMY test can be requested by any pregnant woman who wants to be certain for the rest of her pregnancy that her foetus is not affected by any of the foetal chromosome aberrations monitored by the test. NIPT results contain information on some of the most frequently occurring genetic chromosomal abnormalities (up to 85 % of all foetal genetic disorders). However, the tests cannot detect all potential genetic or other developmental disorders.

TRISOMY test is particularly suitable for pregnant women:

who have growing concerns about their baby’s potential disability as a result of one of the trisomy types monitored;
who are 35 or older at the time of childbirth and whose biochemical screening test results were negative (combined test, triple test, serum integrated test, integrated test);
who conceived as a result of IVF;
with positive biochemical screening results, which have to be confirmed by further testing (amniocentesis);*
whose ultrasound screening test results suggest a higher risk of the trisomy types monitored;*
who have already carried babies with a chromosomal abnormality before;*
whose parent(s) has/have been diagnosed with Robertson balancing translocation (an increased trisomy 13 or 21 risk);*
who have suffered recurrent miscarriage;*
who want to avoid amniocentesis or are suffering from complications that increase the risk of amniocentesis, such as: an increased risk of spontaneous miscarriage, impaired blood clotting, immunization risk due to Rh incompatibility (Rh-negative), the period between the 14th and the 16th weeks of pregnancy, uterine myoma, or placenta praevia.

* The test must be preceded by a genetic consultation.

TRISOMY test XY or TRISOMY test + can be requested by any pregnant woman following a consultation with a specialist in medical genetics. It is suitable for:

pregnant women who have previously been diagnosed with one of the foetal chromosome disorders monitored by TRISOMY test XY or TRISOMY test +;
pregnant women with an increased risk of potential foetal disability caused by one of the syndromes targeted by TRISOMY test XY or TRISOMY test +, e.g. based on ultrasound screening results;
for enhancing the accuracy of standard TRISOMY test screening (e.g. in multiple pregnancies);
pregnant women who want to avoid amniocentesis or are suffering from complications that increase the risk of amniocentesis, such as: an increased risk of spontaneous miscarriage, impaired blood clotting, immunization risk due to Rh incompatibility (Rh-negative), the period between the 14th and the 16th weeks of pregnancy, uterine myoma, or placenta praevia.